Key Takeaways On Feb. 6, 2026, FDA announced that it would take action to restrict access to GLP-1 ingredients for non-FDA ...

A federal regulatory crackdown on Hims could impact a broader network of compounding pharmacies and telehealth companies.

Compounding can build wealth. Resilience can protect it. Together, they can anchor long-term success. In today’s uncertain world, betting on a concentrated portfolio may be a risky gamble. Diversify ...

Still life of Ozempic and Wegovy. Both are injectable prescription weight loss medicines. (Photo by: Michael Siluk/UCG/Universal Images Group via Getty Images) As demand surges for semaglutide ...

Unlike conventional pharmacies, which mostly dispense premade drugs in standard doses, compounding pharmacies make, or "compound," medications on the premises, according to federal guidelines. For ...

FDA Moves to Restrict Compounding GLP-1 Ingredients ...

OpenLoop, a company providing operational and tech services to telehealth companies, and compounding pharmacy Triad Rx are being sued in a class action for selling oral tirzepatide. | The complaint ...

Jennie Smith, a seamstress at a ballet school in Kent, Ohio, had been trying to lose weight and keep it off for years. After losing 60 pounds through dieting only to gain 30 of it back, she wanted to ...

With social media fueling the huge demand for drugs like Ozempic, Rybelsus, Wegovy, and Mounjaro, which are helping people to lose more weight than any previous weight loss medications, it’s no ...

Dr. JeFreda R. Brown is a financial consultant, Certified Financial Education Instructor, and researcher who has assisted thousands of clients over a more than two-decade career. She is the CEO of ...